Bioves Pharmaceutical Private Limited
About Bioves Pharmaceutical Private Limited
Data last updated:
Bioves Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85320TG2018PTC123698. Its GSTIN is 36AAHCB7626H1ZJ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vengalrao Patcha and Karnam Venkatakrishna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dno:5 – 9 – 206/2 Plot No.2 Moosapet Idpl Rajiv Gandhi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.28 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹98,187 (net margin 0.2%) and EBITDA of ₹3.87 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 26% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDno:5 – 9 – 206/2 Plot No.2 Moosapet Idpl Rajiv Gandhi Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bioves Pharmaceutical Private Limited
The main business activity of Bioves Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bioves Pharmaceutical Private Limited FY 2025 filings available
Bioves Pharmaceutical Private Limited reported revenue of ₹4.28 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bioves Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 10% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bioves Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.87 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹98,187 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bioves Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bioves Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dhananjay Trexim Pvt Ltd | ₹4.29 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Kanpur, Uttar Pradesh, India |
| Retra Life Sciences Private Limited | ₹4.29 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Bengaluru, Karnataka, India |
| Samarth Pharma Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Maharashtra, India |
| Connectlife Pharma Private Limited | ₹4.28 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | New Delhi, Delhi, India |
| Midway Pharmaceuticals Private Limited | ₹4.28 Cr (FY 2023) | •••• | •••• | 87.0% | •••• | Delhi, India |
| Bioves Pharmaceutical Private Limited this company | ₹4.28 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Hyderabad, Telangana, India |
| Remedial Healthcare India Private Limited | ₹4.27 Cr (FY 2024) | •••• | •••• | 16826133.0% | •••• | Ambala, Haryana, India |
| Rani Life Sciences Private Limited | ₹4.26 Cr (FY 2024) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
| Kuresys Labs Private Limited | ₹4.26 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| VV Labs Private Limited | ₹4.26 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Zenwick Pharma Private Limited | ₹4.25 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Maliankara P.O, Ernakulam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Bioves Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karnam Venkatakrishna Also directs: Bovine Health Care Private Limited | Additional Director | 02 May 2020 | 6 Years 5 Months | Current |
| Vengalrao Patcha Also directs: PVR Global Pharmaceuticals Private Limited | Director | 10 Apr 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of Bioves Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bioves Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bioves Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Srinivasa Raju Chekuri ceased to be Director on 03 Feb 2021.
Credit Ratings, Litigation & Regulatory Alerts for Bioves Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bioves Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bioves Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCB7626H1ZJ | Telangana | Active | 18 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bioves Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioves Pharmaceutical Private Limited
Bioves Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 2018 (8+ years old) and is registered under CIN U85320TG2018PTC123698.
Bioves Pharmaceutical reported revenue of ₹4.28 Cr for FY 2025 (up 10% YoY).
Bioves Pharmaceutical has 2 current directors:
- Karnam Venkatakrishna - Additional Director
- Vengalrao Patcha - Director
Bioves Pharmaceutical reported a net profit of ₹98,187 (net margin 0.2%) and EBITDA of ₹3.87 Lakh (EBITDA margin 0.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bioves Pharmaceutical is 13% over three years and 26% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bioves Pharmaceutical is 36AAHCB7626H1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Bioves Pharmaceutical is U85320TG2018PTC123698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioves Pharmaceutical was incorporated on 10 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Bioves Pharmaceutical by revenue are Dhananjay Trexim Pvt Ltd, Retra Life Sciences Private Limited, Samarth Pharma Private Limited, Connectlife Pharma Private Limited, Midway Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Srinivasa Raju Chekuri ceased to be Director on 03 Feb 2021. Karnam Venkatakrishna was appointed as Additional Director on 02 May 2020. Vengalrao Patcha was appointed as Director on 10 Apr 2018.
The registered office of Bioves Pharmaceutical is at Dno:5 – 9 – 2062 Plot No.2 Moosapet Idpl Rajiv Gandhi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.